相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease
Jacqueline A. Bayliss et al.
JOURNAL OF NEUROSCIENCE (2016)
Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions
Sanna-Mari Aatsinki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy
Teng Jiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
C. A. Bannister et al.
DIABETES OBESITY & METABOLISM (2014)
Metformin-inclusive Therapy Reduces the Risk of Stroke in Patients with Diabetes: A 4-Year Follow-up Study
Yuan-Yang Cheng et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
Marija Dulovic et al.
NEUROBIOLOGY OF DISEASE (2014)
NEUROPROTECTIVE EFFECT OF METFORMIN IN MPTP-INDUCED PARKINSON'S DISEASE IN MICE
S. P. Patil et al.
NEUROSCIENCE (2014)
Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
Krzysztof Łabuzek et al.
Pharmacological Reports (2014)
The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
Sarah J. Mitchell et al.
CELL REPORTS (2014)
mTOR is a key modulator of ageing and age-related disease
Simon C. Johnson et al.
NATURE (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metformin improves healthspan and lifespan in mice
Alejandro Martin-Montalvo et al.
NATURE COMMUNICATIONS (2013)
Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection
Jacqueline A. Bayliss et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2013)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
Jing Wang et al.
CELL STEM CELL (2012)
The Role of Metformin in the Management of NAFLD
Angela Mazza et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
Chee-Hoe Ng et al.
JOURNAL OF NEUROSCIENCE (2012)
Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
Patrick Imfeld et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
Mark L. Wahlqvist et al.
PARKINSONISM & RELATED DISORDERS (2012)
Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
Jiejie Li et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease
Joanne Clark et al.
BMC MEDICAL GENETICS (2011)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
The cardioprotective effects of metformin
Saloua El Messaoudi et al.
CURRENT OPINION IN LIPIDOLOGY (2011)
Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
Arpita Chakraborty et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Mechanisms Underlying Metformin-Induced Secretion of Glucagon-Like Peptide-1 from the Intestinal L Cell
Andrew J. Mulherin et al.
ENDOCRINOLOGY (2011)
GPA protects the nigrostriatal dopamine system by enhancing mitochondrial function
Tamas L. Horvath et al.
NEUROBIOLOGY OF DISEASE (2011)
AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise
Hayley M. O'Neill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
AMP-activated protein kinase is activated in Parkinson's disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Jae-Sun Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice
Julio E. Ayala et al.
DISEASE MODELS & MECHANISMS (2010)
Berberine Suppresses Neuroinflammatory Responses Through AMP-Activated Protein Kinase Activation in BV-2 Microglia
Dah-Yuu Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Paul W. Caton et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Review: Metformin: Potential benefits and use in chronic kidney disease
Helen L. Pilmore
NEPHROLOGY (2010)
Insulin resistance is associated with the pathology of Alzheimer disease The Hisayama Study
T. Matsuzaki et al.
NEUROLOGY (2010)
Metformin Induces a Dietary Restriction-Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1
Brian Onken et al.
PLOS ONE (2010)
Recent progress in the biology and physiology of sirtuins
Toren Finkel et al.
NATURE (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
Diabetes preceding Parkinson's disease onset. A case-control study
Marco D'Amelio et al.
PARKINSONISM & RELATED DISORDERS (2009)
GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism
Yazhou Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Jane A. Driver et al.
DIABETES CARE (2008)
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Feng Jin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease
Goran Bertilsson et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
SirT1 Regulates Energy Metabolism and Response to Caloric Restriction in Mice
Gino Boily et al.
PLOS ONE (2008)
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening
Gurpreet S. Bhamra et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons
Mohamad-Yehia El-Mir et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
SIRT1 transgenic mice show phenotypes resembling calorie restriction
Laura Bordone et al.
AGING CELL (2007)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Type 2 diabetes and the risk of Parkinson's disease
Gang Hu et al.
DIABETES CARE (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo
Masataka Suwa et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Diabetes mellitus and dementia
F. Pasquier et al.
DIABETES & METABOLISM (2006)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease
Yoon Seong Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies - The Honolulu-Asia Aging Study
R Peila et al.
DIABETES (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
